Skip to content

Programmes gradually adopting TB/HIV activities, as funding and technical partners harmonise monitoring and evaluation

Programmes begin to nurture much needed TB/HIV advocacy

Parasitic worm increases HIV infection risk

Gilead now testing ritonavir replacement in human studies

Low level of drug-resistant strains common in untreated patients, but may not affect treatment

HIV persists in the breastmilk of HIV-positive Kenyan mothers on antiretroviral treatment

Herpes simplex virus type 2 reactivations contribute to genital and plasma HIV-1 shedding

Gene that protects against malaria may increase HIV risk in Africans

Gay Men’s Sex Survey: new data on knowledge of the law, use of poppers, oral sex and testing for hepatitis C